"These products are dangerous because they are targeted to patients with serious conditions, where treatment options proven to be safe and effective are available," said Deborah Autor, FDA's director of drug compliance.
The companies cited by the FDA will have 15 days to pull their products off the market. If they do not, the agency can take legal action, including seizing products and taking company officials to court.
